Nicotine Replacement Therapy - Global Market Outlook (2020-2028)
According to Stratistics MRC, the Global Nicotine Replacement Therapy Market is accounted for $44.2 billion in 2020 and is expected to reach $169.55 billion by 2028 growing at a CAGR of 18.3% during the forecast period. Increasing demand for technological advancements and a rise in awareness about the ill-effects of smoking is driving the market growth. However, the stringent regulatory framework may hamper the growth of the market.
Nicotine replacement therapy is a treatment given to people for the cessation of cigarettes. It uses products that supply nicotine at its low dose that contains a high amount of nicotine which as a result causes lung cancer, asthma, and other chronic diseases. Nicotine replacement therapy helps to decrease or avoid consumption of tobacco, intensity, and minimizing craving frequency.
Based on the product, the e-cigarettes segment is going to have lucrative growth during the forecast period due to increasing investments and the rising focus of companies on developing value-added products. By geography, Asia Pacific is going to have high growth during the forecast period due to the favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products.
Some of the key players profiled in the Nicotine Replacement Therapy include British American Tobacco p.l.c, Cipla Inc, Fertin Pharma, Glenmark, Japan Tobacco, Inc, Pfizer, Inc, and Philip Morris Products S.A .
Product Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Nicotine replacement therapy is a treatment given to people for the cessation of cigarettes. It uses products that supply nicotine at its low dose that contains a high amount of nicotine which as a result causes lung cancer, asthma, and other chronic diseases. Nicotine replacement therapy helps to decrease or avoid consumption of tobacco, intensity, and minimizing craving frequency.
Based on the product, the e-cigarettes segment is going to have lucrative growth during the forecast period due to increasing investments and the rising focus of companies on developing value-added products. By geography, Asia Pacific is going to have high growth during the forecast period due to the favorable government initiatives, coupled with an evolving reimbursement landscape for pharmaceutical products.
Some of the key players profiled in the Nicotine Replacement Therapy include British American Tobacco p.l.c, Cipla Inc, Fertin Pharma, Glenmark, Japan Tobacco, Inc, Pfizer, Inc, and Philip Morris Products S.A .
Product Types Covered:
- Nicotine Replacement Therapy
- E-Cigarettes
- Heat-not-Burn Tobacco Products
- Online Pharmacies
- Offline
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT
5.1 Introduction
5.2 Nicotine Replacement Therapy
5.2.1 Chewing Gums
5.2.2 Inhalers & Oral Aerosols
5.2.3 Logenzes
5.2.4 Mouth Sprays
5.2.5 Nasal Spray
5.2.6 Sublingual Tablets
5.2.7 Transdermal Patches
5.3 E-Cigarettes
5.4 Heat-not-Burn Tobacco Products
6 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY DISTRIBUTION CHANNEL
6.1 Introduction
6.2 Online Pharmacies
6.3 Offline
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
7 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 COMPANY PROFILING
9.1 British American Tobacco p.l.c
9.2 Cipla Inc
9.3 Fertin Pharma
9.4 Glenmark
9.5 Japan Tobacco, Inc
9.6 Pfizer, Inc
9.7 Philip Morris Products S.A
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY PRODUCT
5.1 Introduction
5.2 Nicotine Replacement Therapy
5.2.1 Chewing Gums
5.2.2 Inhalers & Oral Aerosols
5.2.3 Logenzes
5.2.4 Mouth Sprays
5.2.5 Nasal Spray
5.2.6 Sublingual Tablets
5.2.7 Transdermal Patches
5.3 E-Cigarettes
5.4 Heat-not-Burn Tobacco Products
6 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY DISTRIBUTION CHANNEL
6.1 Introduction
6.2 Online Pharmacies
6.3 Offline
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
7 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET, BY GEOGRAPHY
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 KEY DEVELOPMENTS
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 COMPANY PROFILING
9.1 British American Tobacco p.l.c
9.2 Cipla Inc
9.3 Fertin Pharma
9.4 Glenmark
9.5 Japan Tobacco, Inc
9.6 Pfizer, Inc
9.7 Philip Morris Products S.A
LIST OF TABLES
1 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY REGION (2019-2028) ($MN)
2 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
3 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
4 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
5 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
6 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
7 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
8 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
9 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
10 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
11 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
12 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
13 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
14 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
15 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
16 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
17 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
18 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
19 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
20 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
21 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
22 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
23 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
24 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
25 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
26 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
27 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
28 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
29 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
30 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
31 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
32 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
33 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
34 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
35 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
36 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
37 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
38 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
39 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
40 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
41 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
42 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
43 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
44 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
45 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
46 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
47 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
48 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
49 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
50 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
51 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
52 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
53 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
54 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
55 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
56 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
57 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
58 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
59 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
60 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
61 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
62 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
63 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
64 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
65 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
66 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
67 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
68 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
69 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
70 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
71 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
72 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
73 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
74 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
75 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
76 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
77 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
78 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
79 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
80 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
81 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
82 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
83 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
84 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
85 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
86 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
87 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
88 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
89 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
90 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
91 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
92 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
93 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
94 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
95 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
96 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
97 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
98 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
99 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
100 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
101 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
102 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
1 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY REGION (2019-2028) ($MN)
2 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
3 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
4 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
5 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
6 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
7 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
8 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
9 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
10 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
11 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
12 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
13 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
14 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
15 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
16 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
17 GLOBAL NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
18 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
19 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
20 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
21 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
22 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
23 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
24 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
25 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
26 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
27 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
28 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
29 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
30 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
31 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
32 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
33 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
34 NORTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
35 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
36 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
37 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
38 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
39 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
40 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
41 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
42 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
43 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
44 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
45 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
46 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
47 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
48 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
49 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
50 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
51 EUROPE NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
52 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
53 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
54 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
55 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
56 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
57 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
58 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
59 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
60 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
61 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
62 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
63 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
64 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
65 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
66 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
67 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
68 ASIA PACIFIC NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
69 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
70 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
71 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
72 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
73 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
74 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
75 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
76 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
77 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
78 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
79 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
80 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
81 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
82 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
83 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
84 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
85 SOUTH AMERICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
86 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY COUNTRY (2019-2028) ($MN)
87 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY PRODUCT (2019-2028) ($MN)
88 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NICOTINE REPLACEMENT THERAPY (2019-2028) ($MN)
89 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY CHEWING GUMS (2019-2028) ($MN)
90 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY INHALERS & ORAL AEROSOLS (2019-2028) ($MN)
91 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY LOGENZES (2019-2028) ($MN)
92 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY MOUTH SPRAYS (2019-2028) ($MN)
93 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY NASAL SPRAY (2019-2028) ($MN)
94 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY SUBLINGUAL TABLETS (2019-2028) ($MN)
95 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY TRANSDERMAL PATCHES (2019-2028) ($MN)
96 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY E-CIGARETTES (2019-2028) ($MN)
97 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HEAT-NOT-BURN TOBACCO PRODUCTS (2019-2028) ($MN)
98 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY DISTRIBUTION CHANNEL (2019-2028) ($MN)
99 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY ONLINE PHARMACIES (2019-2028) ($MN)
100 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY OFFLINE (2019-2028) ($MN)
101 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY HOSPITAL PHARMACIES (2019-2028) ($MN)
102 MIDDLE EAST & AFRICA NICOTINE REPLACEMENT THERAPY MARKET OUTLOOK, BY RETAIL PHARMACIES (2019-2028) ($MN)
